FR3731M - Nouveaux sulfonamides utilisables en thérapeutique, notamment comme agents chimiothérapiques. - Google Patents

Nouveaux sulfonamides utilisables en thérapeutique, notamment comme agents chimiothérapiques.

Info

Publication number
FR3731M
FR3731M FR966452A FR966452A FR3731M FR 3731 M FR3731 M FR 3731M FR 966452 A FR966452 A FR 966452A FR 966452 A FR966452 A FR 966452A FR 3731 M FR3731 M FR 3731M
Authority
FR
France
Prior art keywords
therapy
chemotherapeutic agents
new sulfonamides
sulfonamides
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR966452A
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
BASF Schweiz AG
Original Assignee
Ciba Geigy AG
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1473462A external-priority patent/CH441364A/de
Priority claimed from FR956575A external-priority patent/FR1403654A/fr
Application filed by Ciba Geigy AG, Ciba AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of FR3731M publication Critical patent/FR3731M/fr
Active legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69Benzenesulfonamido-pyrimidines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR966452A 1962-12-14 1964-03-06 Nouveaux sulfonamides utilisables en thérapeutique, notamment comme agents chimiothérapiques. Active FR3731M (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH1473462A CH441364A (de) 1962-12-14 1962-12-14 Verfahren zur Herstellung neuer Sulfonamide
CH244763 1963-02-26
CH1313463 1963-10-25
FR956575A FR1403654A (fr) 1963-12-10 1963-12-10 Alcoxy-alcoyl-6-(p-amino-benzène-sulfonamido)-pyrimidines et leur procédé de préparation

Publications (1)

Publication Number Publication Date
FR3731M true FR3731M (fr) 1965-12-06

Family

ID=27173721

Family Applications (1)

Application Number Title Priority Date Filing Date
FR966452A Active FR3731M (fr) 1962-12-14 1964-03-06 Nouveaux sulfonamides utilisables en thérapeutique, notamment comme agents chimiothérapiques.

Country Status (8)

Country Link
DE (2) DE1445607A1 (es)
DK (3) DK116284B (es)
ES (1) ES294470A1 (es)
FI (1) FI43991B (es)
FR (1) FR3731M (es)
GB (2) GB1021395A (es)
NO (1) NO115842B (es)
SE (2) SE311654B (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB886693A (en) * 1959-03-04 1962-01-10 Ici Ltd Heterocyclic compounds

Also Published As

Publication number Publication date
GB1035917A (en) 1966-07-13
DK117634B (da) 1970-05-19
FI43991B (es) 1971-04-30
DK115550B (da) 1969-10-20
NO115842B (es) 1968-12-16
DE1445607A1 (de) 1968-12-05
ES294470A1 (es) 1964-06-01
GB1021395A (en) 1966-03-02
DK116284B (da) 1969-12-29
DE1248055B (de) 1967-08-24
SE311654B (es) 1969-06-23
SE321476B (es) 1970-03-09

Similar Documents

Publication Publication Date Title
DK105511C (da) Skøjte.
FR1325M (fr) Nouveaux aminoacétylenes.
FR3290M (fr) Nouvelles amines utilisables en thérapeutique, notamment comme inhibiteurs de la mono-aminoxydase.
FR1280481A (fr) Cathéter applicable, notamment, en urologie
FR3818M (fr) Nouvel imidazole utilisable en thérapeutique, notamment comme agent antischistosomien et antiamibien.
FR2691M (fr) Nouveaux a-nor-b-homo-stéroides utilisables en thérapeutique, notamment comme gestagenes.
FR3731M (fr) Nouveaux sulfonamides utilisables en thérapeutique, notamment comme agents chimiothérapiques.
FR2744M (fr) Nouveaux sulfonamides utlisables en thérapeutique, notamment comme agents chimiothérapiques.
FR2715M (fr) Nouveuax sulfonamides utilisables en thérapeutique, notamment comme agents chimiothérapiques.
FR1035M (fr) Agent chimiothérapeutique.
FR3308M (fr) Nouvelles pipérazines utilisables en thérapeutique, notamment comme agents anti-inflammatoires.
FR2737M (fr) Nouveaux alcoylthiostéroides.
FR3015M (fr) Nouveaux a-nor-b-homo-stéroides utilisables en thérapeutique, notamment comme agents anabolisants.
FR2506M (fr) Nouveaux diphényl-alcanes utilisables en thérapeutique, notamment comme fongicides.
DK96335C (da) Puslespil.
FR2714M (fr) Nouveau sulfonamide utilisable en thérapeutique, notamment comme agent chimiothérapique.
FR3248M (fr) Nouveau sulfonamide utilisable en thérapeutique, notamment comme agent chimiothérapique.
FR2998M (fr) Nouvelles guanidines utilisables en thérapeutique, notamment comme hypoglycémiants.
FR2067M (fr) Nouveaux hydrazides utilisables en thérapeutique, notamment comme agents antibactériens.
FR3359M (fr) Nouveaux indanes utilisables en thérapeutique, notamment comme fongicides.
FR3864M (fr) Nouvelles pipérazines utilisables en thérapeutique, notamment comme agents hypotenseurs.
FR2365M (fr) Nouvelles guanidines utilisables en thérapeutique, notamment comme hypoglycémiants.
FR3503M (fr) Nouveaux composés de phtalazinium utilisables en thérapeutique, notamment comme vermicides.
DK107262C (da) Mejetærsker.
DK104485C (da) Mejetærsker.